CREDIT SUISSE AG/ - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607AB6. A total of 43 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$1,305,408
-59.2%
800,000
-55.6%
0.00%
-75.0%
Q3 2022$3,196,000
+33.4%
1,800,000
-7.6%
0.00%
+100.0%
Q2 2022$2,395,000
-12.2%
1,948,0000.0%0.00%0.0%
Q1 2022$2,728,000
+26.1%
1,948,000
+26.1%
0.00%
+100.0%
Q4 2021$2,163,000
+96.6%
1,545,000
+40.5%
0.00%0.0%
Q3 2021$1,100,000
+120.0%
1,100,000
+120.0%
0.00%
Q2 2021$500,000
-23.4%
500,0000.0%0.00%
Q1 2021$653,000
-53.2%
500,000
-12.1%
0.00%
-100.0%
Q4 2020$1,395,000
+18.2%
569,0000.0%0.00%0.0%
Q3 2020$1,180,000
-9.6%
569,0000.0%0.00%0.0%
Q2 2020$1,306,000
+157.1%
569,000
+69.9%
0.00%
Q1 2020$508,000
-40.7%
335,000
-23.9%
0.00%
-100.0%
Q4 2019$856,000
+159.4%
440,000
+76.0%
0.00%
Q3 2019$330,000
-40.6%
250,0000.0%0.00%
Q2 2019$556,000
-91.9%
250,000
-93.5%
0.00%
-100.0%
Q1 2019$6,902,0003,825,0000.01%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
DeepCurrents Investment Group LLC 82,499,000$120,618,0003.75%
WOLVERINE ASSET MANAGEMENT LLC 76,497,000$112,118,0001.04%
Verition Fund Management LLC 24,689,000$36,219,0000.26%
Baker Brothers Advisors 29,174,000$42,695,0000.21%
ADVENT CAPITAL MANAGEMENT /DE/ 6,858,000$10,032,0000.17%
LORD, ABBETT & CO. LLC 48,435,000$71,054,0000.16%
Calamos Advisors LLC 21,131,000$30,817,0000.12%
PALISADE CAPITAL MANAGEMENT, LP 3,218,000$4,726,0000.10%
Point72 Asset Management, L.P. 9,507,000$13,948,0000.06%
BALYASNY ASSET MANAGEMENT L.P. 10,000,000$14,609,0000.05%
View complete list of SAREPTA THERAPEUTICS INC shareholders